Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × Adrenal Insufficiency × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 69 Breast Neoplasms 45 Colorectal Neoplasms 40 Neoplasms 34 Multiple Myeloma 27 Advanced Solid Tumors 25 Lung Neoplasms 24 Carcinoma, Hepatocellular 24 Prostatic Neoplasms 23 Ovarian Neoplasms 22 Small Cell Lung Carcinoma 21 Recurrence 21 Pancreatic Neoplasms 21 Neoplasm Metastasis 19 Advanced Solid Tumor 19 Glioblastoma 18 Leukemia, Myeloid, Acute 16 Endometrial Neoplasms 15 Stomach Neoplasms 13 Melanoma 13 Glioma 13 Lymphoma, Follicular 11 Uterine Cervical Neoplasms 10 Triple Negative Breast Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Lymphoma 10 Head and Neck Neoplasms 10 Urinary Bladder Neoplasms 9 Sarcoma 9 Non-Muscle Invasive Bladder Neoplasms 9

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡